Home > Insider Trading > Filing (0001209191-20-042498)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1661460	Poseida Therapeutics Inc.	PSTX	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1619884	David Hirsch	C/O Poseida Therapeutics, Inc. 9390 Towne Centre Drive, Suite 200 San Diego CA 92121		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-07-14	2,464,245	$0.00	2,464,245	No	4	C	Indirect	See footnote
Common Stock	Acquisiton	2020-07-14	250,000	$16.00	2,714,245	No	4	P	Indirect	See footnote

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See footnote
No	4	P	Indirect	See footnote

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series B Preferred Stock	Disposition	2020-07-14	2,581,755	$0.00	2,070,373	$0.00
Common Stock	Series C Preferred Stock	Disposition	2020-07-14	491,159	$0.00	393,872	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Indirect
0			No	4	C	Indirect

Footnotes

Each share of the Issuer's Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") automatically converted into 0.8019246 shares of the Issuer's common stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
Represents shares held by Longitude Venture Partners III, L.P. ("LVP III"). Longitude Capital Partners III, LLC ("LCP III") is the general partner of LVP III and may be deemed to have voting, investment and dispositive power over securities held by LVP III. The reporting person is a member of LCP III and may be deemed to share voting, investment and dispositive power with respect to securities held by LVP III. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.